Europe faces a massive public debt. In response Governments reduce health care expenditures. Norvegians in 2003 have excluded from reimbursement in first intention all anti hypertensive drugs except thiazide (one of the less expensive drug of the category). France lowered the reimbursement rate from 100 percent to 65 percent for all anti-hypertensive drugs by suppressing Hypertension from the list of sever affections. Since last year these hardening of social laws were planned by government to reduce the public dept by savings on drugs among other things.
In 2010 Norvegian government softened the rule by admitting other categories than thiazide to the reimbursement in first intention (preferred drugs).
Norwegians have implemented a study to survey the changes in treatment habits. We certainly should do the same in France.